Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Receptor Tyrosine Protein Kinase ERBB 4 Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 PB-357
      • 1.3.3 NT-113
      • 1.3.4 NRG-4
      • 1.3.5 MIN-301
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Application (2019-2025)
      • 1.4.2 Skin Cancer
      • 1.4.3 Systolic Heart Failure
      • 1.4.4 Neuroblastoma
      • 1.4.5 Oligodendroglioma
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size
      • 2.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue 2014-2025
      • 2.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales 2014-2025
    • 2.2 Receptor Tyrosine Protein Kinase ERBB 4 Growth Rate by Regions
      • 2.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Regions 2014-2019
      • 2.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Receptor Tyrosine Protein Kinase ERBB 4 Sales by Manufacturers
      • 3.1.1 Receptor Tyrosine Protein Kinase ERBB 4 Sales by Manufacturers 2014-2019
      • 3.1.2 Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Concentration Ratio (CR5 and HHI)
    • 3.3 Receptor Tyrosine Protein Kinase ERBB 4 Price by Manufacturers
    • 3.4 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 4 Market
    • 3.6 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 PB-357 Sales and Revenue (2014-2019)
      • 4.1.2 NT-113 Sales and Revenue (2014-2019)
      • 4.1.3 NRG-4 Sales and Revenue (2014-2019)
      • 4.1.4 MIN-301 Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type
    • 4.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type
    • 4.4 Receptor Tyrosine Protein Kinase ERBB 4 Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application

    6 United States

    • 6.1 United States Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Company
    • 6.2 United States Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Type
    • 6.3 United States Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Application

    7 European Union

    • 7.1 European Union Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Company
    • 7.2 European Union Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Type
    • 7.3 European Union Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Application

    8 China

    • 8.1 China Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Company
    • 8.2 China Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Type
    • 8.3 China Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Company
    • 9.2 Rest of World Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Type
    • 9.3 Rest of World Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Application
    • 9.4 Rest of World Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Countries
      • 9.4.1 Rest of World Receptor Tyrosine Protein Kinase ERBB 4 Sales by Countries
      • 9.4.2 Rest of World Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Aslan Pharmaceuticals Pte Ltd
      • 10.1.1 Aslan Pharmaceuticals Pte Ltd Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.1.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.1.5 Aslan Pharmaceuticals Pte Ltd Recent Development
    • 10.2 Boehringer Ingelheim GmbH
      • 10.2.1 Boehringer Ingelheim GmbH Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.2.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.2.5 Boehringer Ingelheim GmbH Recent Development
    • 10.3 GamaMabs Pharma SA
      • 10.3.1 GamaMabs Pharma SA Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.3.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.3.5 GamaMabs Pharma SA Recent Development
    • 10.4 Hanmi Pharmaceuticals Co Ltd
      • 10.4.1 Hanmi Pharmaceuticals Co Ltd Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.4.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.4.5 Hanmi Pharmaceuticals Co Ltd Recent Development
    • 10.5 Jiangsu Kanion Pharmaceutical Co Ltd
      • 10.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.5.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Recent Development
    • 10.6 Minerva Neurosciences Inc
      • 10.6.1 Minerva Neurosciences Inc Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.6.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.6.5 Minerva Neurosciences Inc Recent Development
    • 10.7 Pfizer Inc
      • 10.7.1 Pfizer Inc Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.7.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.7.5 Pfizer Inc Recent Development
    • 10.8 Puma Biotechnology Inc
      • 10.8.1 Puma Biotechnology Inc Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.8.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.8.5 Puma Biotechnology Inc Recent Development
    • 10.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
      • 10.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.9.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development
    • 10.10 XuanZhu Pharma Co Ltd
      • 10.10.1 XuanZhu Pharma Co Ltd Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 4
      • 10.10.4 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
      • 10.10.5 XuanZhu Pharma Co Ltd Recent Development
    • 10.11 Zensun (Shanghai) Sci & Tech Co Ltd

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Receptor Tyrosine Protein Kinase ERBB 4 Sales Channels
      • 11.2.2 Receptor Tyrosine Protein Kinase ERBB 4 Distributors
    • 11.3 Receptor Tyrosine Protein Kinase ERBB 4 Customers

    12 Market Forecast

    • 12.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales and Revenue Forecast 2019-2025
    • 12.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Type
    • 12.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Application
    • 12.4 Receptor Tyrosine Protein Kinase ERBB 4 Forecast by Regions
      • 12.4.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Receptor Tyrosine Protein Kinase ERBB 4 is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Receptor Tyrosine Protein Kinase ERBB 4.

      This report studies the global market size of Receptor Tyrosine Protein Kinase ERBB 4, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Receptor Tyrosine Protein Kinase ERBB 4 sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Aslan Pharmaceuticals Pte Ltd
      Boehringer Ingelheim GmbH
      GamaMabs Pharma SA
      Hanmi Pharmaceuticals Co Ltd
      Jiangsu Kanion Pharmaceutical Co Ltd
      Minerva Neurosciences Inc
      Pfizer Inc
      Puma Biotechnology Inc
      Shanghai Fosun Pharmaceutical (Group) Co Ltd
      XuanZhu Pharma Co Ltd
      Zensun (Shanghai) Sci & Tech Co Ltd

      Market Segment by Product Type
      PB-357
      NT-113
      NRG-4
      MIN-301
      Others

      Market Segment by Application
      Skin Cancer
      Systolic Heart Failure
      Neuroblastoma
      Oligodendroglioma
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Receptor Tyrosine Protein Kinase ERBB 4 status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Receptor Tyrosine Protein Kinase ERBB 4 manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Receptor Tyrosine Protein Kinase ERBB 4 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now